BioSpace News Archive

Imara Inc. announced that the company will host a conference call and live webcast on Friday, August 6, 2021, at 8:30 a.m. ET to discuss its financial results for the quarter ended June 30, 2021 and review recent business highlights.

Cerevel Therapeutics announced that on August 30, 2021 at 5:00 p.m. ET, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement, dated as of June 9, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.

IDEXX Laboratories, Inc., a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced second quarter results, as well as an update on U.S. companion animal diagnostics sector trends.

IN8bio, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies utilizing its DeltEx platform, announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $10.00 per share, for gross proceeds of $40 million, before underwriting discounts and commissions and estimated offering expenses.

Radiology has emerged as a significant tool for diagnosis of several diseases and has played an extremely powerful role in the supervision of treatment and prediction of the outcome.

Microcentrifuge tubes are made of a polyethylene resin or an ultra-clear polypropylene that allows for easy viewing of contents.

BioArctic AB’s partner Eisai held several presentations at the Alzheimer’s Association International Conference in Denver, Colorado July 26 to 30, 2021.

Desalting is a process, wherein salts are removed from a sample. Buffer exchange involves replacing one set of buffer salts by another.

Takeda Pharmaceutical Company Limited announced financial results for the first quarter of fiscal year 2021.

In accordance with the decision at the board meeting on 8 July 2021, Vitrolife AB has issued a total of 9,645,303 new shares.